- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00177268
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
Peripheral Blood, Urine and Skin Sample Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
This is a tissue, urine, and blood banking protocol for cutaneous t-cell lymphoma (CTCL), eczema, and atopic dermatitis patients for current and future research.
Study Overview
Status
Intervention / Treatment
Detailed Description
The purpose of this study is to provide a central mechanism for monitoring access to peripheral blood, urine, and skin specimens obtained from CTCL, eczema, and atopic dermatitis patients to monitor:
- immunologic assays/flow cytometry
- tumor progression/regression
- genomic studies
- proteomic studies
- others germane to the advancement of CTCL treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Charity L Ruhl, LPN
- Phone Number: 4126472013
- Email: ruhlcl@upmc.edu
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15213
- Recruiting
- University of Pittsburgh Medical Center
-
Contact:
- Oleg Akilov, MD, PhD
- Phone Number: 412-647-4200
- Email: akilovoe@upmc.edu
-
Sub-Investigator:
- Louis Falo, M.D., Ph.D.
-
Sub-Investigator:
- Patrizia Fuschiotti, PhD
-
Sub-Investigator:
- Hassane Zarour, MD
-
Principal Investigator:
- Oleg E. Akilov, MD, Ph.D
-
Sub-Investigator:
- Nicolena Verardi, PA-C
-
Contact:
- Charity L Ruhl, LPN
- Phone Number: 4126472013
- Email: ruhlcl@upmc.edu
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Subjects with cutaneous t-cell lymphoma and/or Sezary syndrome and atopic dermatitis or eczema patients
Description
Inclusion Criteria:
- 18 or older
- able and willing to provide informed consent
- diagnosed with CTCL
- diagnosed with either atopic dermatitis or eczema
Exclusion Criteria:
- Lack of CTCL, atopic dermatitis, or eczema diagnosis in medical record
Study Plan
How is the study designed?
Design Details
- Observational Models: OTHER
- Time Perspectives: PROSPECTIVE
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
CTCL, atopic dermatitis, eczema
Those subjects with cutaneous t-cell lymphoma and Sezary syndrome, atopic dermatitis, or eczema may participate as appropriate with the potential for blood, tissue or urine sampling. |
Up to 9 blood draws/year of 60 ml of whole blood. One 6 mm punch biopsy may be obtained up to 4 times per year. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proteomics of Cutaneous T-cell lymphoma
Time Frame: Ongoing
|
Proteomic variables will be measured in blood and tissue of consented CTCL patients. |
Ongoing
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Oleg E Akilov, M.D., PhD, University of Pittsburgh
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Neoplasms
- Genetic Diseases, Inborn
- Immune System Diseases
- Neoplasms by Histologic Type
- Hypersensitivity, Immediate
- Hypersensitivity
- Skin Diseases
- Lymphatic Diseases
- Lymphoproliferative Disorders
- Immunoproliferative Disorders
- Lymphoma, Non-Hodgkin
- Lymphoma
- Skin Diseases, Genetic
- Skin Diseases, Eczematous
- Dermatitis
- Lymphoma, T-Cell
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities
- Skin and Connective Tissue Diseases
- Hemic and Lymphatic Diseases
- Dermatitis, Atopic
- Eczema
- Lymphoma, T-Cell, Cutaneous
- Mycosis Fungoides
- Sezary Syndrome
- Investigative Techniques
- Specimen Handling
- Clinical Laboratory Techniques
- Diagnostic Techniques and Procedures
- Diagnosis
- Punctures
- Surgical Procedures, Operative
- Blood Specimen Collection
- Urine Specimen Collection
Other Study ID Numbers
- STUDY19010322
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.